Results 1 to 10 of about 1,156,270 (203)
What’s hidden behind Lennox-Gastaut syndrome?
A number of epileptologists often diagnose Lennox-Gastaut syndrome, while others almost never do. It is necessary to understand why this is happening, especially since Lennox-Gastaut syndrome, according to literature descriptions, is quite common.
E. D. Belousova
doaj +2 more sources
Lennox–Gastaut syndrome is an epileptic encephalopathy with onset in childhood. The classical triad of diagnostic criteria is well known: 1) presence of various types of refractory epileptic seizures (tonic, atypical absences, myoclonic, tonic/atonic ...
E. D. Belousova +3 more
doaj +2 more sources
Neurocisticercose e síndrome de lennox-gastaut: relato de caso Neurocysticercosis and Lennox-Gastaut syndrome: case report [PDF]
Relata-se o caso de uma menina que, aos 2 anos de idade, apresentou a forma epiléptica, hidrocefálica e encefalítica da neurocisticercose, diagnosticada por exame do líquido cefalorraqueano e tomografia computadorizada de crânio, evolução com crises ...
SVETLANA AGAPEJEV +3 more
doaj +2 more sources
Fenfluramine for seizures in Dravet syndrome and Lennox-Gastaut syndrome: Mechanisms, clinical evidence, safety, and practical integration [PDF]
Developmental and epileptic encephalopathies such as Dravet syndrome and Lennox–Gastaut syndrome remain highly drug resistant and are associated with substantial neurodevelopmental, behavioral, and caregiver burdens.
József Janszky +2 more
doaj +2 more sources
Differential Diagnosis of Lennox-Gastaut Syndrome
Epileptologists from Children's Hospital, Boston, and UCLA, California, discuss approaches to the differential diagnosis of Lennox Gastaut syndrome (LGS) and identification of a possible underlying etiology.
J Gordon Millichap, John J Millichap
doaj +2 more sources
Felbamate in Lennox-Gastaut Syndrome
The Felbamate Study Group report results in 73 patients ages 4 to 36 years with the Lennox-Gastaut syndrome, using a double-blind, placebo- controlled, add-on trial design.
J Gordon Millichap
doaj +2 more sources
PHARMACOECONOMIC EVALUATION OF RUFINAMIDE USE FOR THE LENNOX-GASTAUT SYNDROME TREATMENT [PDF]
Among epileptic encephalopathies, the Lennox–Gastaut syndrome is considered to be one of the most severe. It is a childhood-onset disease that leads to early disability and mental retardation and is associated with significant costs of medical care and ...
N. K. Mazina +3 more
doaj +2 more sources
Levetiracetam efficacy in patients with Lennox-Gastaut syndrome. Presentation of a case
Introduction: The Lennox-Gastaut syndrome (LGS) is one of the most severe epileptic encephalopathies of childhood, characterized by electro-clinical triad of generalized peak-slow wave activity (PSW) in the electroencephalogram (EEG), multiple types of ...
A. Díaz Negrillo +4 more
doaj +2 more sources
Topiramate in Lennox-Gastaut Syndrome
The efficacy and safety of topiramate as adjunctive therapy for Lennox-Gastaut syndrome were studied in an 11-week multicenter, double-blind, placebo-controlled trial involving 98 patients, 1-30 years of age, and reported from the New Jersey-Robert Wood ...
J Gordon Millichap
doaj +2 more sources
Demonstration of antibody and cellular immune response to brain extract in West and Lennox-Gastaut syndromes [PDF]
We investigated humoral and cellular immune response to brain tissues in 15 patients with West syndrome, in 9 patients with Lennox-Gastaut syndrome and in 20 healthy children.
Norma G. S. Mota +3 more
doaj +2 more sources

